{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T21:21:46Z","timestamp":1649020906979},"reference-count":31,"publisher":"Informa Healthcare","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1517\/14656566.7.10.1409","type":"journal-article","created":{"date-parts":[[2006,6,29]],"date-time":"2006-06-29T16:48:54Z","timestamp":1151599734000},"page":"1409-1412","source":"Crossref","is-referenced-by-count":2,"title":["Overcoming resistance with designer immunotoxins"],"prefix":"10.1517","volume":"7","author":[{"given":"Martin","family":"Braddock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2006,6,29]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nrmicro848","volume":"2","author":"KIOY","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"CIT0002","volume-title":"Parasitic Diseases, 5th edn.","author":"DESPOMMIER","year":"2005"},{"key":"CIT0003","doi-asserted-by":"crossref","unstructured":"DUMAS S, BISSER S: Clinical aspects of human African trypanosomiasis. In:Progress in Human African Trypanosomiasis, Sleeping Sickness. Springer-Verlag, Paris (1999):215-233.","DOI":"10.1007\/978-2-8178-0857-4_13"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0035-9203(80)90184-4","volume":"74","author":"GREENWOOD","year":"1980","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mib.2004.05.001","volume":"7","author":"PAYS","year":"2004","journal-title":"Curr. Opin. Microbiol."},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2174\/1566524043360078","volume":"4","author":"HORN","year":"2004","journal-title":"Curr. Mol. Med."},{"key":"CIT0007","first-page":"1474","volume":"78","author":"DUMAS","year":"2000","journal-title":"Bull. WHO"},{"key":"CIT0008","first-page":"190","volume":"46","author":"ITEN","year":"1995","journal-title":"Trop. Med. Parasitol."},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1472-8206.2003.00167.x","volume":"17","author":"BOUTEILLE","year":"2003","journal-title":"Fundam. Clin. Pharmacol."},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-3156.2002.00933.x","volume":"7","author":"MPIA","year":"2002","journal-title":"Trop. Med. Int. Health"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3201\/eid1106.050036","volume":"11","author":"PEPIN","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001432-200412000-00009","volume":"17","author":"JANNIN","year":"2004","journal-title":"Current Opinion in Infectious Diseases"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1473-3099(02)00321-3","volume":"2","author":"LEGROS","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"CIT0014","first-page":"1086","volume":"6","author":"YEATES","year":"2003","journal-title":"Idrugs"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ijpara.2004.04.008","volume":"34","author":"VANHAMME","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0166-6851(94)90172-4","volume":"68","author":"DE GREEF","year":"1994","journal-title":"Mol. Biochem. Parasitol."},{"key":"CIT0017","first-page":"55","volume":"56","author":"VAN MEIRVENNE","year":"1976","journal-title":"Ann. Soc. Belg. Med. Trop."},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0092-8674(00)81706-7","volume":"95","author":"XONG","year":"1998","journal-title":"Cell"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","volume":"422","author":"VANHAMME","year":"2003","journal-title":"Nature"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","volume":"363","author":"HAMERS-CASTERMAN","year":"1993","journal-title":"Nature"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nsb0996-733","volume":"3","author":"SHERRIF","year":"1996","journal-title":"Nat Struct Biol."},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0968-0004(01)01790-X","volume":"26","author":"MUYLDERMANS","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1074\/jbc.M307341200","volume":"279","author":"STIJLEMANS","year":"2004","journal-title":"J. Biol. Chem."},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.1114566","volume":"309","author":"PEREZ-MORGA","year":"2005","journal-title":"Science"},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1158\/0008-5472.CAN-03-3935","volume":"64","author":"CORTEZ-RETAMOZO","year":"2004","journal-title":"Cancer Res."},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/ijc.10212","volume":"98","author":"CORTEZ-RETAMOZO","year":"2002","journal-title":"Int. J. Cancer"},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jmb.2005.04.050","volume":"350","author":"CONRATH","year":"2005","journal-title":"J. Mol. Biol."},{"key":"CIT0028","unstructured":"GHAROUDI MA, DESMYTER A, MUYLDERMANS S, HAMERS R: Identification of soluble, stable camel VH antibody fragments expressed in E.coli, with specificity and neutralizing activity for tetanus toxoid.9th Forum of Applied Biotechnology, Med. Fac. Landbouw Univ. Gent.(1995) 60\/4a Part I:2097-2100."},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0923-2494(98)80011-4","volume":"149","author":"FRENKEN","year":"1998","journal-title":"Res. Immunol."},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0168-1656(99)00228-X","volume":"78","author":"FRENKEN","year":"2000","journal-title":"J. Biotechnol."},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00253-004-1689-0","volume":"66","author":"JOOSTEN","year":"2005","journal-title":"Appl. Microbiol. Biotechnol."}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.7.10.1409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T17:38:50Z","timestamp":1555695530000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.7.10.1409"}},"subtitle":["BARAL TN, MAGEZ S, STIJLEMANS B<i>et al.<\/i>: Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.<i>Nat. Med.<\/i>(2006)<b>12<\/b>(5) 580-584."],"short-title":[],"issued":{"date-parts":[[2006,6,29]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2006,6,29]]},"published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.1517\/14656566.7.10.1409"],"URL":"https:\/\/doi.org\/10.1517\/14656566.7.10.1409","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,29]]}}}